Search research articles
Contact Us
Filters
Showing results (11-20 of 103) with videos related to
Page
of 11
Sort By:
Oncotarget
|
April 9, 2016
Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway
Mileidys Pérez-Alea, Ana Vivancos, Ginevra Caratú, et al.
Scientific Reports
|
June 22, 2019
Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
Ana Vivancos, Enrique Aranda, Manuel Benavides, et al.
Cancer Treatment Reviews
|
February 26, 2022
Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis
Andri Papakonstantinou, Nadia Saoudi Gonzalez, Isabel Pimentel, et al.
Pigment Cell & Melanoma Research
|
December 25, 2015
Genetic evolution of nevus of Ota reveals clonal heterogeneity acquiring BAP1 and TP53 mutations
Ana Vivancos, Ginevra Caratú, Judit Matito, et al.
Frontiers in Oncology
|
March 25, 2026
Case Report: Lorlatinib for the treatment of <i>ALK</i>-rearranged poorly differentiated thyroid carcinoma after progression to prior ALK-specific tyrosine-kinase inhibitor
Jesús Yaringaño, Jorge Hernando, Alejandro García-Álvarez, et al.
Scientific Reports
|
September 21, 2019
Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer
Garazi Serna, Fiorella Ruiz-Pace, Fabiola Cecchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2023
Clinical and genomic characterisation of early-onset pancreatic cancer
Florian Castet, Carles Fabregat-Franco, Gloria Castillo, et al.
Journal for Immunotherapy of Cancer
|
April 28, 2022
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
Joan Frigola, Caterina Carbonell, Patricia Irazno, et al.
JCO Precision Oncology
|
January 9, 2025
Targeted Next-Generation Sequencing in Succinate Dehydrogenase-Deficient GI Stromal Tumor Identifies Actionable Alterations in the PI3K/mTOR Pathway
Carlo María Cicala, Judit Matito, María Quindos, et al.
Nature Genetics
|
October 2, 2007
EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells
Carme Cortina, Sergio Palomo-Ponce, Mar Iglesias, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 103) with videos related to
Sort By:
Page
of 11
Oncotarget
|
April 9, 2016
Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway
Mileidys Pérez-Alea, Ana Vivancos, Ginevra Caratú, et al.
Scientific Reports
|
June 22, 2019
Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
Ana Vivancos, Enrique Aranda, Manuel Benavides, et al.
Cancer Treatment Reviews
|
February 26, 2022
Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis
Andri Papakonstantinou, Nadia Saoudi Gonzalez, Isabel Pimentel, et al.
Pigment Cell & Melanoma Research
|
December 25, 2015
Genetic evolution of nevus of Ota reveals clonal heterogeneity acquiring BAP1 and TP53 mutations
Ana Vivancos, Ginevra Caratú, Judit Matito, et al.
Frontiers in Oncology
|
March 25, 2026
Case Report: Lorlatinib for the treatment of <i>ALK</i>-rearranged poorly differentiated thyroid carcinoma after progression to prior ALK-specific tyrosine-kinase inhibitor
Jesús Yaringaño, Jorge Hernando, Alejandro García-Álvarez, et al.
Scientific Reports
|
September 21, 2019
Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer
Garazi Serna, Fiorella Ruiz-Pace, Fabiola Cecchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2023
Clinical and genomic characterisation of early-onset pancreatic cancer
Florian Castet, Carles Fabregat-Franco, Gloria Castillo, et al.
Journal for Immunotherapy of Cancer
|
April 28, 2022
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
Joan Frigola, Caterina Carbonell, Patricia Irazno, et al.
JCO Precision Oncology
|
January 9, 2025
Targeted Next-Generation Sequencing in Succinate Dehydrogenase-Deficient GI Stromal Tumor Identifies Actionable Alterations in the PI3K/mTOR Pathway
Carlo María Cicala, Judit Matito, María Quindos, et al.
Nature Genetics
|
October 2, 2007
EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells
Carme Cortina, Sergio Palomo-Ponce, Mar Iglesias, et al.
Page
of 11